Invention Grant
US08715659B2 Single domain brain-targeting antibody fragments derived from llama antibodies
有权
衍生自美洲驼抗体的单结构域脑靶向抗体片段
- Patent Title: Single domain brain-targeting antibody fragments derived from llama antibodies
- Patent Title (中): 衍生自美洲驼抗体的单结构域脑靶向抗体片段
-
Application No.: US13773734Application Date: 2013-02-22
-
Publication No.: US08715659B2Publication Date: 2014-05-06
- Inventor: Arumugam Muruganandam , Jamshid Tanha , Saran Narang , Danica Stanimirovic
- Applicant: National Researh Council of Canada
- Applicant Address: CA Ottawa
- Assignee: National Research Council of Canada
- Current Assignee: National Research Council of Canada
- Current Assignee Address: CA Ottawa
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; A61K39/38 ; C07K14/00 ; C07K17/00

Abstract:
A phage-displayed library of llama single heavy domain antibodies (sdAbs) was enriched for species that selectively bind to and are internalized by human cerebromicrovascular endothelial cells (HCEC). From the enriched library, two sdAbs were selected, sequenced, subcloned, and expressed as fusion proteins with c-myc-His5 tags (His5 is SEQ ID NO:101). Similarly as phage-displayed sdAbs, these soluble tagged sdAbs were shown to selectively bind to HCEC and to transmigrate across in vitro human blood-brain barrier (BBB) model. In contrast to an unrelated llama sdAb, these sdAbs were also detected in the brain after i.v. injection into mice. These small (˜13 kDa) antibody fragments have essential characteristics of brain-specific delivery vectors and can be used to facilitate drug transport across the BBB.
Public/Granted literature
- US20130150561A1 SINGLE-DOMAIN BRAIN-TARGETING ANTIBODY FRAGMENTS DERIVED FROM LLAMA ANTIBODIES Public/Granted day:2013-06-13
Information query